Summary
Human α-galactosidase (EC 3.2.1.22) is a lysosomal hydrolase encoded by a single gene located in the chromosomal region Xq21.33-q22. The deficient activity of this enzyme results in Fabry disease, an X-linked recessive disorder which leads to premature death in affected males. For studies of the structure and function of α-galactosidase and for characterization of the genetic lesions in families with Fabry disease, the full-length cDNA was isolated, sequenced and used to obtain the human chromosomal gene. The 1393 bp full-length cDNA had a 60 nt 5’ untranslated region and encoded a precursor peptide of 429 amino acids including a signal peptide of 31 residues. The functional integrity of this cDNA was demonstrated by transient expression in COS-1 cells. The entire ~12 kb chromosomal gene, including ~9 and ~11 kb of 5’ and 3’ flanking sequence, was isolated. The gene had seven exons whose sequences were identical to those in the full-length cDNA. The 5’ flanking region of this housekeeping gene contained Spl and CCAAT box promoter elements as well as sequences corresponding to the AP-1, “OCTA” and “core” enhancer elements. Four direct repeats of the “chorion box” enhancer were preceded by an upstream “HTF” island. All intron-exon splice junctions conformed to the GT/AG consensus sequence. The novel lack of a 3’ untranslated sequence in the α-galactosidase cDNA was confirmed by sequencing the genomic 3’ region.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
R. J. Desnick and C. C. Sweeley, Fabry disease: α-galactosidase A deficiency, in: “The Metabolic Basis of Inherited Disease,.” J. B. Stanbury, J. B. Wyngaarden, D. S, Fredrickson, J. L. Goldstein, and M. S. Brown, eds., McGraw-Hill, New York, 5th ed., (1982).
D. F. Bishop and R. J. Desnick, Affinity purification of α-galactosidase A from human spleen, placenta and plasma with elimination of pyrogen contamination, J. Biol. Chem. 256:1307 (1982).
J. W. Mayes and E. Beutler, Alpha-galactosidase A from human placenta. Stability and subunit size, Biochim. Biophys. Acta 484:408 (1977).
J. W. Kusiak, J. M. Quirk, and R. O. Brady, Purification and properties of the two major isozymes of α-galactosidase from human placenta, J. Biol. Chem. 253:184 (1978).
K. J. Dean and C. C. Sweeley, Studies on human liver α-galactosidase, J. Biol. Chem. 254:9994(1979).
E. Beutler and W. Kuhl, Purification and properties of human α-galactosidase, J. Biol. Chem. 247:7195 (1972).
P. Lemansky, D. F. Bishop, R. J. Desnick, A. Hasilik, and K von Figura, Synthesis and processing of α-galactosidase A in human fibroblasts: Evidence for different mutations in Fabry disease, J. Biol. Chem. 262:2062 (1987).
H. S. Bernstein, D. F. Bishop, K H. Astrin, R. Kornreich and R. J. Desnick, Fabry disease: Analysis of mutations in the human α-galactosidase gene, Am. J. Hum. Genet. 39A188 (1986).
D. H. Calhoun, D. F. Bishop, H. S. Bernstein, M. Quinn, P. Hantzopoulos and R. J. Desnick, Isolation of a cDNA clone encoding human α-galactosidase A, Proc. Natl. Acad. Sci. USA 82:7364 (1985)
D. F. Bishop, D. H. Calhoun, H. S. Bernstein, P. Hantzopoulos, M. Quinn and R. J. Desnick, Human a-galactosidase A: Nucleotide sequence of a cDNA clone encoding the mature enzyme, Proc. Natl. Acad. Sci. USA 83:4859 (1986).
R. J. Desnick, K. H. Astrin, H. S. Bernstein, V. R. Potluri and D. F. Bishop, Molecular studies of Fabiy disease, Clin Res. 34:717A (1986).
D. F. Bishop, R. Kornreich, and R. J. Desnick, Structural organization of the human agalactosidase A gene: Further evidence for the absence of a 3’ untranslated region, Proc. Natl Acad. Sci. USA 85:3903 (1988).
H. Okayama and P. Berg, A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells, Mol. Cell Biol 3:280 (1983).
W. I. Wood, D. J. Capon, C. C. Simonsen, D. L. Eaton, J. Gitschier, B. Keyt, P. H. See burg, D. H. Smith, P. Hollingshead, K. L. Wion, E. Delwart, G. D. Tuddenham, G. A. Vehar and R. M. Lawn, Expression of active human factor VIII from recombinant DNA clones, Nature 312:330 (1984).
H. Okayama and P. Berg, High-efficiency cloning of full-length cDNA, Mol. Cell Biol. 2:161 (1982).
D. Han ah an and M. Meselson, Plasmid screening at high colony density, Methods Enzymol. 100:333 (1983).
W. D. Benton and R. W. Davis, Screening Xgt recombinant clones by hybridization in situf Science 196:180 (1977).
J. Messing, New M13 vectors for cloning, Methods Enzymol 101:20 (1983).
F. Sanger, S. Nicklen, and A. R. Coulson, DNA sequencing with chain-terminating inhibitors, Proc. Natl. Acad. Sci. USA 74:5463 (1977).
G. G. Wong, J. S. Witek, P. A. Temple, K. M. Wilkens, A. C. Leary, D. P. Luxenberg, S. S. Jones, E. L. Brown, R. M. Kay, E. C. Orr, C. Shoemaker, D. W. Golde, R. J. Kaufman, R. H. Hewick, E. A. Wang, and S. C. Clark, Human GM-CSF: Molecular cloning of the complementary DNA and purification of the natural and recombinant proteins, Science 228:810 (1985).
S. Kaway and M. Nishizawa, New procedure for DNA transfection with polycation and dimethyl sulfoxide, Mol Cell Biol 4:1172 (1984).
T. L. Morgan, V. M. Maher, and J. J. McCormick, Optimal parameters for the polybreneinduced DNA transfection of diploid human fibroblasts, In Vitro Cell. Devel Biol. 22:317 (1986).
D. F. Bishop, K. J. Dean, C. C. Sweeley, and R. J. Desnick, Purification and characterization of human a-galactosidase isozymes: Comparison of tissue and plasma forms and evaluation of purification methods, it:“Enzyme Therapy in Genetic Diseases: 2,” R. J. Desnick, ed., Alan R. Liss, Inc., New York p. 17 (1980).
P. Bohlen, S. Stein, W. Dairman, and S. Udenfriend, Fluorometric assay of proteins in the nanogram range, Arch. Biochem. Biophys. 155:213 (1973).
D. F. Bishop, D. E. Wampler, J. T. Sgouris, R. J. Bonefeld, D. K. Anderson, M. C. Hawley, and C. C. Sweeley, Pilot scale purification of a-galactosidase A from Cohn fraction IV-1 of human plasma, Biochim. Biophys. Acta 524:109 (1978).
J. M. Chirgwin, A. E. Przybyla, R. J. MacDonald, and W. J. Rutter, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry 18:5294 (1974).
T. Maniatis, E. F. Fritsch, and J. Sambrook, “Molecular Cloning: A Laboratory Manual” Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. (1982).
F. R. Blattner, B. G. Williams, A. E. Blechl, K. Denniston-Thompson, H. E. Faber, L. A. Furlong, D. J. Grunwald, D. O. Kiefer, D. D. Moore, E. L. Sheldon, and O. Smithies, Charon phages: Safer derivatives of bacteriophage lambda for DNA cloning, Science 196:161 (1977).
E. Southern, Detection of specific sequences among DNA fragments separated by gel electrophoresis, J. Mol Biol 9:503 (1975).
M. Kozak, Compilation and analysis of sequences upstream from the translation start site in eukaryotic mRNA’s, Nucleic Acids Res. 12:857 (1984).
D. Perlman and H. O. Halvorson, A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides, J.Mol. Biol 167:391 (1983).
M. E. E. Watson, Compilation of published signal sequences, Nucleic Acids Res. 12:5141 (1984).
G. von Heijne, A new method for predicting signal sequence cleavage sites, Nucleic Acids Res. 14:4683 (1986).
S. Tsuji, B. M. Martin, D. C. Kaslow, B. R. Migeon, P. V. Choudary, B. K. Stubblefield, J A. Mayor, G. J. Murray, J. A. Barranger, and E. I. Ginns, Signal sequence and DNA mediated expression of human lysosomal a-galactosidase A, Eur. J. Biochem. 165:27 (1987).
J. Sorge, C. West, B. Westwood, and E. Beutler, Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA, Proc. Natl Acad. Sci. USA 82:7289 (1985).
P. L. Faust, S. Kornfeld, and J. M. Chirgwin, Cloning and sequence analysis of cDNA for human cathepsin D, Proc. Natl Acad. Sci. USA 82:4910 (1985).
R. Myerowitz, R. Piekarz, E. F. Neufeld, T. B. Shows, and K Suzuki, Human β-Hex osaminidase a-chain: Coding sequence and homology with the β-chain, Proc. Natl. Acad, Sci. USA 82:7830 (1985).
M. Luskey and M. Batchan, Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences, Nature 293:79 (1981).
J. Logan and T. Shenk, Adenovirus tripartite leader sequence enhances translation on mRNAs late after infection, Proc. Natl. Acad. Sci. USA 81:3655 (1984).
R. J. Schneider, C. Weinberger and T. Shenk, Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cells, Cell 37:291 (1984).
R. Breathnach and P. Chambon, Organization and expression of eukaryotic split genes coding for proteins, Ann. Rev. Biochem. 50:349 (1981).
S. M. Mount, A catalogue of splice junction sequences, Nucleic Acids Res. 10:459 (1982).
B. Ruskin, A. R. Krainer, T. Maniatis, and M. R. Green, Excision of an intact intron as novel lariat structure during pre-mRNA splicing in vitro, Cell 38:317 (1984).
E. B. Keller and W. A. Noon, Intron splicing: A conserved internal signal in introns oi Drosophila pre-mRNAf Nucleic Acids Res. 13:4971 (1985).
R. L. Proia and E. Soravia, Organization of the gene encoding the human β-hex osaminidase a-chain, J. Biol Chem. 262:5677 (1987).
R. L. Proia, Gene encoding the human β-hexosaminidase β-chain: Extensive homology o intron placement in the a-and β-chain genes, Proc. Natl. Acad. Sci. USA 85:1833 (1988).
W. Gilbert, Genes-in-pieces revisited, Science 228:823 (1985).
T. Maniatis, S. Goodbourn, and J. A. Fischer, Regulation of inducible and tissue-specific gene expression, Science 236:1237 (1987).
J. Cordon, B. Wasylyk, A. Buchwalder, P. Sassone-Corsi, C. Kedinger, and P. Chambon Promoter sequences of eukaryotic protein-coding genes, Science 209:1406 (1980).
C. Benoist and P. Chambon, In vivo sequence requirements of the SV40 early promote] region, Nature 290:304 (1981).
A.P. Bird, CpG-rich islands and the function of DNA methylation, Nature 321:209 (1986).
S. Lindsay and A. P. Bird, Use of restriction enzymes to detect potential gene sequences in mammalian DNA, Nature 327:336 (1987).
D. Valerio, M. G. C. Duyvesteyn, B. M. M. Bekker, G. Weeda, Th. M. Berkvens, L. var der Voorn, H. van Ormondt, and A. J. van der Eb, Adenosine deaminase: Characterizatior and expression of a gene with a remarkable promoter, EMBO 4:437 (1985).
G. A. Reynolds, S. K Basu, T. F. Osborne, D. J. Chin, G. Gil, J. L. Goldstein, and K L Luskey, HMG-CoA reductase: A negatively regulated gene with unusual promoter and 5 untranslated regions, Cell 38:275 (1984).
D. W. Melton, D. S. Konecki, J. Brennand, and T. C. Caskey, Structure, expression anc mutation of the hypoxanthine phosphoribosyltransferase gene, Proc. Natl. Acad, Sci. USA 81:2147 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this paper
Cite this paper
Bishop, D.F., Kornreich, R., Eng, C.M., Ioannou, Y.A., Fitzmaurice, T.F., Desnick, R.J. (1988). Human α-Galactosidase: Characterization and Eukaryotic Expression of the Full-Length cDNA and Structural Organization of the Gene. In: Salvayre, R., Douste-Blazy, L., Gatt, S. (eds) Lipid Storage Disorders. NATO ASI Series, vol 150. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1029-7_102
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1029-7_102
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8300-3
Online ISBN: 978-1-4613-1029-7
eBook Packages: Springer Book Archive